Current Edition


Novartis may have a buyer for $21B generics unit Sandoz

Amid the industrywide push by Big Pharmas to spin off their generics and consumer businesses, Novartis may be on the verge of separating itself from …

Continue Reading →

Merck women’s health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy

When Merck’s women’s health spinoff Organon launched in June, it promised to listen to—and amplify—women’s voices on overlooked health concerns. Now, the company is getting …

Continue Reading →

Organon shares jump as Merck’s new women’s health spinoff posts strong start for biosims, infertility drugs

It’s been a mere two months since Merck’s women’s health spinoff Organon set off to chart its own path as an independent company. That hasn’t …

Continue Reading →